The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells

PURPOSE: As radiation therapy is widely used for the management of pancreatic cancer, identifying novel targets to improve the radiosensitivity of cancer cells is beneficial. Rosiglitazone, a specific peroxisome proliferator-activated receptor γ (PPARγ) agonist, has an inhibitory effect on various t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Des Devel Ther
Main Authors: Wang, Zhenyu, Shen, Wenhao, Li, Xugang, Feng, Yang, Qian, Kun, Wang, Gaoren, Gao, Yiying, Xu, Xiaohui, Zhang, Shuyu, Yue, Ling, Cao, Jianping
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7410396/
https://ncbi.nlm.nih.gov/pubmed/32801648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S242557
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados